Cohen Fred E
Insider CIK 1339358 · GHDX Director · FPRX Director · CDNA Director · VCYT Director · TNDM Director, 10% owner · ROKA Director · PGNY Director · NTLA Director · URGN Director · KYTX Director, 10% owner · BCRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CDNA CareDx, Inc. | A Award | 2026-06-12 | 2026-06-16 | 9,795 | — | $0 | 165,060 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2026-06-09 | 2026-06-10 | 13,300 | — | $0 | 13,300 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2026-06-09 | 2026-06-10 | 9,200 | — | $0 | 216,653 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | A Award deriv | 2026-05-27 | 2026-05-29 | 20,582 | — | $0 | 20,582 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | A Award | 2026-05-27 | 2026-05-29 | 5,093 | — | $0 | 21,727 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | P Buy | 2026-01-05 | 2026-01-07 | 150,000 | $9.35 | $1.40M | 207,453 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2025-06-13 | 2025-06-17 | 12,103 | — | $0 | 155,265 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2025-06-11 | 2025-06-13 | 11,450 | — | $0 | 11,450 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2025-06-11 | 2025-06-13 | 8,000 | — | $0 | 57,453 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | A Award deriv | 2025-05-29 | 2025-06-02 | 65,351 | — | $0 | 65,351 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | A Award | 2025-05-29 | 2025-06-02 | 16,634 | — | $0 | 16,634 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2024-08-06 | 2024-08-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CDNA CareDx, Inc. | A Award deriv | 2024-06-14 | 2024-06-18 | 16,048 | — | $0 | 16,048 | SEC↗ |
| CDNA CareDx, Inc. | A Award deriv | 2024-06-14 | 2024-06-20 | 16,048 | — | $0 | 16,048 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2024-06-14 | 2024-06-18 | 10,570 | — | $0 | 143,162 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2024-06-12 | 2024-06-14 | 11,515 | — | $0 | 11,515 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2024-06-12 | 2024-06-14 | 7,737 | — | $0 | 49,453 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2024-05-23 | 2024-05-28 | 25,070 | — | $0 | 25,070 | SEC↗ |
| PGNY Progyny, Inc. | A Award | 2024-05-23 | 2024-05-28 | 6,176 | — | $0 | 22,693 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | C Conversion deriv | 2024-02-12 | 2024-02-14 | 7,356,162 | — | $0 | 0 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | C Conversion deriv | 2024-02-12 | 2024-02-14 | 4,401,771 | — | $0 | 0 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | C Conversion deriv | 2024-02-12 | 2024-02-14 | 8,830,901 | — | $0 | 0 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | C Conversion | 2024-02-12 | 2024-02-14 | 4,523,924 | — | $0 | 4,523,924 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2023-09-07 | 2023-09-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award | 2023-07-26 | 2023-07-28 | 69,339 | $9.54 | $661.5K | 69,339 | SEC↗ |
| CDNA CareDx, Inc. | A Award deriv | 2023-06-16 | 2023-06-21 | 29,136 | — | $0 | 29,136 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2023-06-16 | 2023-06-21 | 18,844 | — | $0 | 132,592 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2023-06-14 | 2023-06-16 | 6,473 | — | $0 | 6,473 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2023-06-14 | 2023-06-16 | 4,425 | — | $0 | 41,716 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2023-05-24 | 2023-05-26 | 18,350 | — | $0 | 18,350 | SEC↗ |
| PGNY Progyny, Inc. | A Award | 2023-05-24 | 2023-05-26 | 4,385 | — | $0 | 16,517 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2023-01-06 | 2023-01-09 | 1,062 | — | $0 | 113,748 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2022-10-24 | 2022-10-26 | 1,460 | — | $0 | 1,460 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2022-10-24 | 2022-10-26 | 15,660 | — | $0 | 15,660 | SEC↗ |
| PGNY Progyny, Inc. | A Award | 2022-10-24 | 2022-10-26 | 3,480 | — | $0 | 12,132 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2022-10-04 | 2022-10-04 | 803 | — | $0 | 112,686 | SEC↗ |
| CDNA CareDx, Inc. | A Award deriv | 2022-06-16 | 2022-06-21 | 7,606 | — | $0 | 7,606 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2022-06-16 | 2022-06-21 | 4,863 | — | $0 | 111,883 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2022-06-14 | 2022-06-16 | 7,688 | — | $0 | 7,688 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2022-06-14 | 2022-06-16 | 5,197 | — | $0 | 37,291 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2022-06-08 | 2022-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2021-10-24 | 2021-10-26 | 15,831 | — | $0 | 15,831 | SEC↗ |
| PGNY Progyny, Inc. | A Award | 2021-10-24 | 2021-10-26 | 2,652 | — | $0 | 8,652 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2021-06-23 | 2021-06-25 | 3,382 | — | $0 | 3,382 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2021-06-23 | 2021-06-25 | 2,094 | — | $0 | 2,094 | SEC↗ |
| CDNA CareDx, Inc. | A Award deriv | 2021-06-16 | 2021-06-21 | 1,812 | — | $0 | 1,812 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2021-06-16 | 2021-06-21 | 1,127 | — | $0 | 107,020 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2021-06-07 | 2021-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2021-01-20 | 2021-01-22 | 20,000 | — | $0 | 18,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2021-01-20 | 2021-01-22 | 20,000 | $13.78 | $275.6K | 30,000 | SEC↗ |
| CDNA CareDx, Inc. | M Exercise deriv | 2021-01-06 | 2021-01-06 | 15,000 | — | $0 | 0 | SEC↗ |
| CDNA CareDx, Inc. | M Exercise | 2021-01-06 | 2021-01-06 | 15,000 | $14.74 | $221.1K | 105,893 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2020-10-24 | 2020-10-27 | 27,000 | — | $0 | 27,000 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2020-10-24 | 2020-10-27 | 894 | $27.95 | $25.0K | 894 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2020-10-24 | 2020-11-20 | 1,845 | — | $0 | 1,845 | SEC↗ |
| PGNY Progyny, Inc. | A Award | 2020-10-24 | 2020-10-27 | 6,000 | — | $0 | 6,000 | SEC↗ |
| VCYT VERACYTE, INC. | M Exercise deriv | 2020-10-19 | 2020-10-20 | 10,000 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | M Exercise | 2020-10-19 | 2020-10-20 | 10,000 | $7.60 | $76.0K | 10,000 | SEC↗ |
| CDNA CareDx, Inc. | M Exercise deriv | 2020-09-21 | 2020-09-22 | 6,679 | — | $0 | 0 | SEC↗ |
| CDNA CareDx, Inc. | M Exercise deriv | 2020-09-21 | 2020-09-22 | 9,745 | — | $0 | 0 | SEC↗ |
| CDNA CareDx, Inc. | M Exercise | 2020-09-21 | 2020-09-22 | 6,679 | $5.49 | $36.7K | 81,148 | SEC↗ |
| CDNA CareDx, Inc. | M Exercise | 2020-09-21 | 2020-09-22 | 9,745 | $4.95 | $48.2K | 90,893 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2020-06-18 | 2020-06-19 | 19,000 | — | $0 | 19,000 | SEC↗ |
| CDNA CareDx, Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 4,978 | $31.35 | $156.1K | 4,978 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2020-06-18 | 2020-06-19 | 3,190 | — | $0 | 74,469 | SEC↗ |
| VCYT VERACYTE, INC. | A Award deriv | 2020-06-08 | 2020-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2020-06-08 | 2020-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VCYT VERACYTE, INC. | S Sale | 2020-05-18 | 2020-05-19 | 4,153 | $27.51 | $114.2K | 0 | SEC↗ |
| VCYT VERACYTE, INC. | S Sale | 2020-05-18 | 2020-05-19 | 35,847 | $26.79 | $960.3K | 4,153 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer deriv | 2019-11-08 | 2019-11-14 | 10,000 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer deriv | 2019-11-08 | 2019-11-14 | 10,000 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer deriv | 2019-11-08 | 2019-11-14 | 6,583 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer deriv | 2019-11-08 | 2019-11-14 | 1,515 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer deriv | 2019-11-08 | 2019-11-14 | 8,250 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer deriv | 2019-11-08 | 2019-11-14 | 10,000 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer | 2019-11-08 | 2019-11-14 | 68,165 | — | $0 | 955 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer | 2019-11-08 | 2019-11-14 | 955 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer | 2019-11-08 | 2019-11-14 | 6,068 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2019-10-01 | 2019-10-03 | 185 | $67.28 | $12.4K | 69,120 | SEC↗ |
| VCYT VERACYTE, INC. | M Exercise deriv | 2019-08-02 | 2019-08-05 | 10,000 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | M Exercise deriv | 2019-08-02 | 2019-08-05 | 10,000 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | M Exercise deriv | 2019-08-02 | 2019-08-05 | 10,000 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | M Exercise deriv | 2019-08-02 | 2019-08-05 | 10,000 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | M Exercise | 2019-08-02 | 2019-08-05 | 10,000 | $5.28 | $52.8K | 30,000 | SEC↗ |
| VCYT VERACYTE, INC. | M Exercise | 2019-08-02 | 2019-08-05 | 10,000 | $7.94 | $79.4K | 40,000 | SEC↗ |
| VCYT VERACYTE, INC. | M Exercise | 2019-08-02 | 2019-08-05 | 10,000 | $13.19 | $131.9K | 10,000 | SEC↗ |
| VCYT VERACYTE, INC. | M Exercise | 2019-08-02 | 2019-08-05 | 10,000 | $10.41 | $104.1K | 20,000 | SEC↗ |
| CDNA CareDx, Inc. | M Exercise deriv | 2019-07-11 | 2019-07-15 | 5,255 | — | $0 | 0 | SEC↗ |
| CDNA CareDx, Inc. | M Exercise deriv | 2019-07-11 | 2019-07-15 | 5,255 | — | $0 | 0 | SEC↗ |
| CDNA CareDx, Inc. | M Exercise deriv | 2019-07-11 | 2019-07-15 | 5,255 | — | $0 | 0 | SEC↗ |
| CDNA CareDx, Inc. | M Exercise | 2019-07-11 | 2019-07-15 | 5,255 | $5.85 | $30.7K | 66,024 | SEC↗ |
| CDNA CareDx, Inc. | M Exercise | 2019-07-11 | 2019-07-15 | 5,255 | $10.00 | $52.5K | 60,769 | SEC↗ |
| CDNA CareDx, Inc. | M Exercise | 2019-07-11 | 2019-07-15 | 5,255 | $5.02 | $26.4K | 71,279 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2019-07-01 | 2019-07-03 | 212 | $58.86 | $12.5K | 68,935 | SEC↗ |
| CDNA CareDx, Inc. | A Award deriv | 2019-06-17 | 2019-06-19 | 4,152 | $38.26 | $158.9K | 4,152 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2019-06-17 | 2019-06-19 | 2,613 | — | $0 | 55,514 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2019-06-14 | 2019-06-18 | 6,583 | — | $0 | 6,583 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2019-06-14 | 2019-06-18 | 955 | — | $0 | 68,723 | SEC↗ |
| VCYT VERACYTE, INC. | A Award deriv | 2019-06-12 | 2019-06-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2019-06-03 | 2019-06-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2019-05-21 | 2019-05-22 | 19,000 | — | $0 | 19,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2019-04-01 | 2019-04-03 | 149 | $66.84 | $10.0K | 67,768 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2019-03-01 | 2019-03-05 | 10,000 | $16.89 | $168.9K | 10,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise deriv | 2019-02-22 | 2019-02-26 | 10,000 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise | 2019-02-22 | 2019-02-26 | 10,000 | $26.01 | $260.1K | 77,619 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2019-02-22 | 2019-02-26 | 9,307 | $78.80 | $733.4K | 68,312 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2019-02-22 | 2019-02-26 | 693 | $79.57 | $55.1K | 67,619 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2019-02-06 | 2019-03-22 | 15,000 | — | $0 | 25,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2019-02-06 | 2019-03-22 | 15,000 | $16.99 | $254.8K | 15,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2019-01-23 | 2019-01-24 | 38,000 | — | $0 | 38,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2019-01-01 | 2019-01-03 | 155 | $64.41 | $10.0K | 67,619 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | A Award deriv | 2018-11-15 | 2018-11-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise deriv | 2018-11-08 | 2018-11-13 | 10,000 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2018-11-08 | 2018-11-13 | 403 | $89.50 | $36.1K | 67,464 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2018-11-08 | 2018-11-13 | 4,200 | $88.73 | $372.7K | 67,867 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2018-11-08 | 2018-11-13 | 3,816 | $87.98 | $335.7K | 72,067 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2018-11-08 | 2018-11-13 | 745 | $85.67 | $63.8K | 75,883 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2018-11-08 | 2018-11-13 | 836 | $84.90 | $71.0K | 76,628 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise | 2018-11-08 | 2018-11-13 | 10,000 | $27.75 | $277.5K | 77,464 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2018-10-01 | 2018-10-03 | 142 | $70.18 | $10.0K | 67,464 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise deriv | 2018-09-06 | 2018-09-10 | 8,250 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise | 2018-09-06 | 2018-09-10 | 8,250 | $34.44 | $284.1K | 75,572 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2018-09-06 | 2018-09-10 | 8,250 | $61.51 | $507.5K | 67,322 | SEC↗ |
| CDNA CareDx, Inc. | M Exercise deriv | 2018-08-28 | 2018-08-29 | 15,000 | — | $0 | 0 | SEC↗ |
| CDNA CareDx, Inc. | M Exercise | 2018-08-28 | 2018-08-29 | 15,000 | $1.22 | $18.3K | 52,901 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise deriv | 2018-08-07 | 2018-08-09 | 8,250 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2018-08-07 | 2018-08-09 | 1,400 | $56.81 | $79.5K | 67,322 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise | 2018-08-07 | 2018-08-09 | 8,250 | $25.79 | $212.8K | 75,572 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2018-08-07 | 2018-08-09 | 6,850 | $56.10 | $384.3K | 68,722 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2018-07-01 | 2018-07-03 | 198 | $50.40 | $10.0K | 67,322 | SEC↗ |
| CDNA CareDx, Inc. | A Award deriv | 2018-06-20 | 2018-07-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2018-06-20 | 2018-07-03 | 5,000 | — | $0 | 37,901 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2018-06-20 | 2018-06-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| VCYT VERACYTE, INC. | A Award deriv | 2018-06-07 | 2018-06-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2018-06-07 | 2018-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2018-04-01 | 2018-04-03 | 319 | $31.29 | $10.0K | 67,124 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2018-01-01 | 2018-01-03 | 292 | $34.20 | $10.0K | 66,805 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | A Award deriv | 2017-12-01 | 2017-12-05 | 5,300 | — | $0 | 5,300 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | A Award deriv | 2017-11-15 | 2017-11-17 | 1,700 | — | $0 | 1,700 | SEC↗ |
| CDNA CareDx, Inc. | A Award deriv | 2017-11-09 | 2017-11-13 | 6,679 | — | $0 | 6,679 | SEC↗ |
| CDNA CareDx, Inc. | D To issuer deriv | 2017-11-08 | 2017-11-13 | 10,948 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2017-10-01 | 2017-10-03 | 311 | $32.09 | $10.0K | 66,513 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2017-09-18 | 2017-09-20 | 54,250 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2017-09-18 | 2017-09-20 | 54,250 | $5.42 | $294.0K | 119,410 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2017-09-18 | 2017-09-20 | 54,250 | $4.27 | $231.6K | 173,660 | SEC↗ |
| CDNA CareDx, Inc. | A Award deriv | 2017-07-13 | 2017-07-14 | 15,000 | $1.22 | $18.3K | 15,000 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2017-07-13 | 2017-07-14 | 5,000 | — | $0 | 32,901 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2017-07-01 | 2017-07-05 | 307 | $32.55 | $10.0K | 66,202 | SEC↗ |
| ROKA Roka BioScience, Inc. | A Award deriv | 2017-06-28 | 2017-06-30 | 3,000 | — | $0 | 3,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2017-06-16 | 2017-06-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VCYT VERACYTE, INC. | A Award deriv | 2017-06-07 | 2017-06-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2017-06-01 | 2017-06-02 | 1,941 | $5.15 | $10.0K | 119,410 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-05-24 | 2017-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise deriv | 2017-05-19 | 2017-05-23 | 8,250 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise | 2017-05-19 | 2017-05-23 | 8,250 | $14.37 | $118.6K | 74,145 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2017-05-19 | 2017-05-23 | 8,250 | $29.54 | $243.7K | 65,895 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise deriv | 2017-05-18 | 2017-05-22 | 8,250 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise deriv | 2017-05-18 | 2017-05-22 | 8,250 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2017-05-18 | 2017-05-22 | 16,500 | $29.88 | $493.0K | 65,895 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise | 2017-05-18 | 2017-05-22 | 8,250 | $17.59 | $145.1K | 82,395 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise | 2017-05-18 | 2017-05-22 | 8,250 | $18.50 | $152.6K | 74,145 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise deriv | 2017-05-16 | 2017-05-18 | 8,250 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2017-05-16 | 2017-05-18 | 8,250 | $30.68 | $253.1K | 65,895 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise | 2017-05-16 | 2017-05-18 | 8,250 | $18.13 | $149.6K | 74,145 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2017-05-10 | 2017-05-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2017-04-01 | 2017-04-04 | 317 | $31.49 | $10.0K | 65,895 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2017-04-01 | 2017-04-04 | 5,271 | — | $0 | 27,901 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2017-03-01 | 2017-03-02 | 1,602 | $6.24 | $10.0K | 117,469 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2017-01-01 | 2017-01-04 | 340 | $29.39 | $10.0K | 65,578 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2017-01-01 | 2017-01-04 | 3,391 | — | $0 | 22,630 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2016-12-01 | 2016-12-02 | 1,788 | $5.59 | $10.0K | 115,867 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | A Award deriv | 2016-11-15 | 2016-11-16 | 17,000 | — | $0 | 17,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2016-10-01 | 2016-10-04 | 345 | $28.92 | $10.0K | 65,238 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2016-10-01 | 2016-10-04 | 2,643 | — | $0 | 19,239 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2016-09-01 | 2016-09-06 | 2,433 | $4.11 | $10.0K | 114,079 | SEC↗ |
| CDNA CareDx, Inc. | A Award deriv | 2016-07-15 | 2016-07-19 | 9,745 | $4.95 | $48.2K | 9,745 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2016-07-15 | 2016-07-19 | 5,000 | — | $0 | 16,596 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2016-07-01 | 2016-07-06 | 373 | $26.74 | $10.0K | 64,893 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2016-07-01 | 2016-07-06 | 2,695 | — | $0 | 11,596 | SEC↗ |
| ROKA Roka BioScience, Inc. | A Award deriv | 2016-06-22 | 2016-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| VCYT VERACYTE, INC. | A Award deriv | 2016-06-20 | 2016-06-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CDNA CareDx, Inc. | A Award deriv | 2016-06-16 | 2016-06-20 | 5,255 | $5.02 | $26.4K | 5,255 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2016-06-10 | 2016-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2016-05-31 | 2016-06-02 | 2,581 | $3.39 | $8.7K | 111,646 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2016-05-23 | 2016-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2016-05-19 | 2016-05-23 | 10,000 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2016-04-01 | 2016-04-04 | 392 | $25.48 | $10.0K | 64,520 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2016-04-01 | 2016-04-05 | 1,954 | — | $0 | 8,901 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2016-02-29 | 2016-03-01 | 4,396 | $1.99 | $8.7K | 109,065 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-01-11 | 2016-01-13 | 4,065 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-01-11 | 2016-01-13 | 4,065 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-01-11 | 2016-01-13 | 12,500 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-01-11 | 2016-01-13 | 4,065 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-01-11 | 2016-01-13 | 4,065 | $5.54 | $22.5K | 8,242 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-01-11 | 2016-01-13 | 4,065 | $8.49 | $34.5K | 4,177 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-01-11 | 2016-01-13 | 12,500 | $12.70 | $158.8K | 24,807 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-01-11 | 2016-01-13 | 4,065 | $7.26 | $29.5K | 12,307 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2016-01-01 | 2016-01-05 | 284 | $35.20 | $10.0K | 64,128 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2016-01-01 | 2016-01-05 | 1,836 | — | $0 | 6,947 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2015-11-30 | 2015-12-03 | 824 | $10.61 | $8.7K | 104,669 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | A Award deriv | 2015-11-16 | 2015-11-17 | 17,000 | — | $0 | 17,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2015-10-01 | 2015-10-05 | 468 | $21.34 | $10.0K | 63,844 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2015-10-01 | 2015-10-05 | 1,008 | — | $0 | 5,111 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2015-08-31 | 2015-09-02 | 751 | $11.64 | $8.7K | 103,845 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2015-07-01 | 2015-07-06 | 365 | $27.34 | $10.0K | 63,376 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2015-07-01 | 2015-07-06 | 1,227 | — | $0 | 4,103 | SEC↗ |
| ROKA Roka BioScience, Inc. | A Award deriv | 2015-06-24 | 2015-06-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CDNA CareDx, Inc. | A Award deriv | 2015-06-17 | 2019-07-15 | 5,255 | — | $0 | 5,255 | SEC↗ |
| CDNA CareDx, Inc. | A Award deriv | 2015-06-16 | 2015-06-17 | 5,255 | $6.08 | $32.0K | 5,255 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2015-06-12 | 2015-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2015-06-12 | 2015-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2015-05-29 | 2015-06-01 | 780 | $11.21 | $8.7K | 103,094 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-05-20 | 2015-05-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VCYT VERACYTE, INC. | A Award deriv | 2015-05-19 | 2015-05-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2015-04-01 | 2015-04-03 | 328 | $30.43 | $10.0K | 63,011 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2015-04-01 | 2015-04-03 | 1,075 | — | $0 | 2,876 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2015-02-27 | 2015-03-03 | 857 | $10.20 | $8.7K | 102,314 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2015-01-08 | 2015-01-09 | 100,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2015-01-08 | 2015-01-09 | 100,000 | $1.29 | $129.0K | 101,457 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2015-01-01 | 2015-01-05 | 1,143 | — | $0 | 1,801 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2015-01-01 | 2015-01-05 | 312 | $31.97 | $10.0K | 62,683 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2014-11-28 | 2014-12-03 | 809 | $10.81 | $8.7K | 1,457 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | A Award deriv | 2014-11-17 | 2014-11-20 | 17,000 | — | $0 | 17,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2014-10-01 | 2014-10-03 | 350 | $28.54 | $10.0K | 62,371 | SEC↗ |
| CDNA CareDx, Inc. | A Award | 2014-10-01 | 2014-10-03 | 658 | — | $0 | 658 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2014-08-29 | 2014-09-02 | 648 | $13.50 | $8.7K | 648 | SEC↗ |
| CDNA CareDx, Inc. | A Award deriv | 2014-07-21 | 2014-07-23 | 5,255 | — | $0 | 16,203 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | J Other | 2014-07-01 | 2014-07-03 | 55 | — | $0 | 55 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | J Other | 2014-07-01 | 2014-07-03 | 57 | — | $0 | 112 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2014-07-01 | 2014-07-03 | 358 | $27.86 | $10.0K | 62,021 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2014-06-06 | 2014-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VCYT VERACYTE, INC. | A Award deriv | 2014-05-20 | 2014-05-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2014-05-16 | 2014-05-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-05-02 | 2014-05-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2014-04-01 | 2014-04-03 | 376 | $26.57 | $10.0K | 61,663 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2014-01-01 | 2014-01-03 | 341 | $29.27 | $10.0K | 61,287 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | A Award deriv | 2013-11-13 | 2013-11-15 | 17,000 | — | $0 | 17,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2013-10-01 | 2013-10-03 | 329 | $30.33 | $10.0K | 60,946 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2013-07-25 | 2013-07-29 | 1,515 | — | $0 | 1,515 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2013-07-22 | 2013-07-24 | 20,833 | $3.72 | $77.5K | 20,833 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2013-07-01 | 2013-07-03 | 303 | $32.85 | $10.0K | 60,617 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2013-06-07 | 2013-06-11 | 8,250 | — | $0 | 8,250 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2013-04-01 | 2013-04-03 | 357 | $27.99 | $10.0K | 60,314 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2013-01-01 | 2013-01-03 | 367 | $27.24 | $10.0K | 59,957 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2012-10-01 | 2012-10-03 | 288 | $35.89 | $10.3K | 59,590 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise deriv | 2012-08-01 | 2012-08-31 | 8,250 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise | 2012-08-01 | 2012-08-31 | 8,250 | $10.73 | $88.5K | 59,302 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2012-07-01 | 2012-07-03 | 299 | $33.40 | $10.0K | 51,052 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2012-06-08 | 2012-06-12 | 8,250 | — | $0 | 8,250 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2012-04-01 | 2012-04-03 | 326 | $30.61 | $10.0K | 50,753 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2012-01-01 | 2012-01-06 | 393 | $25.39 | $10.0K | 50,427 | SEC↗ |